Sorafenib Tosylate | Interleukin Related interleukin-related.com

Product Name :
Sorafenib Tosylate

Search keywords :
Sorafenib

drugId :
null

Target Vo:
Vascular endothelial growth factor receptor 1

Target Vo Short Name :
VEGFR1

Moa_Name:
Vascular endothelial growth factor receptor 3 antagonists

First Approval Country :
United States

First Approval Date Filter:
2005

Origin Company_Name :
Onyx Pharmaceuticals Inc

Active Company_Name :
Bayer AG

Active Indication_Name:
Thyroid Neoplasms

In Active Indication_Name:
Burkitt Lymphoma

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BTK Antibody (YA816)
IDH1 Antibody
COX IV Antibody: COX IV Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to COX IV. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts